Abiomed
ABMD
#1118
Rank
C$23.89 B
Marketcap
$529.92
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : C$0.21 Billion

According to Abiomed's latest financial reports the company's total liabilities are C$0.21 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abiomed - Total liabilities on balance sheet (from 2013 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-03-31C$0.21 B2.14%
2021-03-31C$0.20 B-2.92%
2020-03-31C$0.21 B36.54%
2019-03-31C$0.15 B25.39%
2018-03-31C$0.12 B-4.63%
2017-03-31C$0.13 B83.19%
2016-03-31C$71.57 M20.66%
2015-03-31C$59.31 M44.88%
2014-03-31C$40.94 M22.25%
2013-03-31C$33.49 M21.46%
2012-03-31C$27.57 M5.73%
2011-03-31C$26.07 M18.81%
2010-03-31C$21.95 M-12.92%
2009-03-31C$25.2 M0.61%
2008-03-31C$25.05 M53.64%
2007-03-31C$16.3 M54.37%
2006-03-31C$10.56 M78.89%
2005-03-31C$5.9 M-6.54%
2004-03-31C$6.31 M-31.13%
2003-03-31C$9.17 M-43.61%
2002-03-31C$16.27 M10.45%
2001-03-31C$14.73 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$4.17 B 1,816.71%๐Ÿ‡บ๐Ÿ‡ธ USA
C$22.94 B 10,425.21%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.20 B-4.28%๐Ÿ‡บ๐Ÿ‡ธ USA